Lipitor Patent
Nov 30, 2011 at 14:50 | Source: Moneycontrol.com
Nov 22, 2011 at 22:02 | Source: CNBC-TV18
Apr 12, 2011 at 10:51 | Source: Reuters
Mar 15, 2010 at 13:20 | Source: Moneycontrol.com
Feb 04, 2009 at 18:49 | Source: CNBC-TV18
Sep 01, 2008 at 10:05 | Source: Moneycontrol.com
News across the web »
Dec 22, 2011 at 22:26 | Source: Livemint
Dec 20, 2011 at 18:36 | Source: Business Today
Dec 01, 2011 at 22:57 | Source: The Hindu BusinessLine
Dec 01, 2011 at 12:44 | Source: Money Rediff News Report
Dec 01, 2011 at 11:18 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Related News »
NEW YORK, May 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of ...
May 23, 2012 at 09:39 | Source: Yahoo Finance
Pfizer Inc.'s Lipitor has been the biggest-selling drug in the world, with annual sales of as much as $13 billion. U.S. patent protection on the drug ended on Nov. 30. Watson Pharmaceuticals Inc. makes the authorized generic version in the U.S ...
May 26, 2012 at 16:17 | Source: Yahoo Finance
Pfizer, too, a curious choice given loss of its Lipitor patent, but the stock has been so beaten down that to many it looks cheap. Among the bottom seven hedge fund favorites, only Express Scripts and Qualcomm outperformed the S&P 500 on a total ...
May 24, 2012 at 01:24 | Source: Forbes
Pfizer Inc. conducted an intriguing experiment in brand marketing this year, aggressively pushing the cholesterol-fighting drug Lipitor in the U.S. even after its patent expired on Nov. 30. But after spending more than $87 million promoting the ...
May 8, 2012 at 23:55 | Source: Wall Street Journal
The copycat version was launched on the first day of patent expiry in the UK, they said in a statement late on Wednesday. Lipitor, chemically known as atorvastatin, is the world's top selling drug with market size of about $16 billion ...
May 17, 2012 at 04:31 | Source: Reuters India
And unlike Pfizer ($PFE), which aggressively plugged its newly off-patent Lipitor, Bristol-Myers Squibb ($BMY) plans to back off Plavix marketing immediately. Bristol-Myers sells Plavix in partnership with Sanofi ($SNY), and both companies have ...
May 16, 2012 at 23:59 | Source: FiercePharma
Pfizer (PFE) is still transitioning itself after its best selling drug Lipitor went off patent in 2011. Also starting in July a marketing partnership between Amgen and Pfizer ends which will result in a large loss of revenue from the blockbuster medication Enbrel.
May 10, 2012 at 16:00 | Source: Seekingalpha.com
The money goes to the chemists. Lipitor is the nation's biggest-selling drug, with more than 10 million subsidised scripts supplied every year. The cholesterol treatment came off patent this month and the Ranbaxy offer is part of a strategy by the generic ...
May 27, 2012 at 13:59 | Source: The Australian
Pfizer's cholesterol fighter Lipitor, which had been the No. 1 seller, began facing generic competition late last year. Bristol and Sanofi had been girding for the May 2012 loss of U.S. patent protection on their biggest revenue source for quite ...
May 17, 2012 at 18:58 | Source: Reuters